ã¹ã¬ãããªããã¯ãç®èã®äžã«ç³žãå ¥ããŠäžãã£ãçµç¹ãåŒãäžããŠåºå®ããæœè¡ã§ããæ¡å ã§ããèŠãPDOïŒäœå ã§æº¶ããå»ççšã®ç³žïŒ6ã8ãæã¯ãå¹æã®æéã§ã¯ãªãã糞ãäœå ã§åžåãããæéãæããŸãã
3è¡ãŸãšã
1. 糞ãåžåãããæéãšãé¡ã®å€åãä¿ãããæéã¯åãã§ã¯ãããŸããã
2. æåºããã詊éšå€ã§ã¯ã糞ã®åŒåŒµåã¯2é±åŸã«çŽ81%ã4é±åŸã«çŽ66%ãŸã§äœäžããŸããã
3. ã«ãŠã³ã»ãªã³ã°ã§ã¯ãææ°ãããçŽ æã»ç³žã®æ§é ã»æ¿å ¥èšç»ã»ä»¥åã®æœè¡æŽãããããŠç¢ºèªããå¿ èŠããããŸãã
åŒåŒµåãåžåãé¡ã®å€åã¯å¥ã ã«é²ã¿ãŸã
糞ã®è¡šé¢ãç®èäžã®çµç¹ã«ããããšãåŒãäžããçµç¹ããã®äœçœ®ã«ä¿ã¡ãŸãããã ããç³žãæ®ã£ãŠãããšããäºå®ãšåœåã®åŒåŒµåãä¿ãããŠãããšããæå³ã¯åãã§ã¯ãããŸããã
ç±³åœã®èŠå¶æ©é¢ã«æåºããã詊éšå€ã§ã¯ãPDO糞ã®åŒåŒµåã¯2é±åŸã«çŽ81%ã4é±åŸã«çŽ66%ãŸã§äœäžããŸãããå¥ã®PDO糞ã®è³æã«ã¯ãåµãæ¯ããæéãæå€§6é±ãšèšãããŠããŸãã糞ãå®å šã«åžåãããåãããç©ççãªåã¯äœäžããŸãã
| åºå | äœãèŠãæ°åã | ã«ãŠã³ã»ãªã³ã°ã§ç¢ºèªããç¹ |
|---|---|---|
| åŒåŒµå | 糞ãåœåã®åãã©ãã ãä¿ã€ã | åžåæéãšåãæ°åãšããŠã¯èŠãŸããã |
| åžåæé | 糞ãäœå ããæ¶ãããŸã§ã«ãããæé | 广ããã®ãŸãŸç¶ãæéãæå³ããŸããã |
| é¡ã®å€å | åŒãäžãã圢ãšçµç¹ã®åããã©ãã ãæ®ãã | åãæ¡ä»¶ã®åçãšçŸåšã®ç¶æ ãããããŠèŠãŸãã |
人ã察象ã«ããè³æã§ããå€åã¯æ©ãæžå°ãå§ããŸãããé¡ã®çåŽã«PDO糞ã3æ¬ãŸãã¯6æ¬å ¥ãã詊éšã§ã¯ã20æ¥ã«èŠãããé ¬ãšé¡äžéšã®å€åã60æ¥ã«æžå°ããŸãããæ¬æ°ã«ããäœç©ã»çµç¹ã®åãã»æºè¶³åºŠã®å·®ã確èªãããŸããã§ããã
è«æ12ç·šãšåå è 818人ããŸãšããè³æã§ã¯ãæœè¡çŽåŸã®æ¹åãè€æ°ã®è©äŸ¡æ¹æ³ã§å ±åãããŸãããæé·ã®è¿œè·¡ã¯2幎ã§ããã鷿广ã倿ããè³æã¯äžè¶³ããŠããç¶æ ã§ãã
PDO 6ã8ãæã广æéãšããŠèªã¿ã«ããçç±
PDO 6ã8ãæãšããæ°åã¯2024幎ã®ã¬ãã¥ãŒã«æ²èŒãããŠããŸãããã®æã®åºå žããã©ããšã2017幎ã«çºè¡šããã1ããŒãžã®åèè³æã«è¡ãçããŸããäž»èŠãªåŠè¡æ€çŽ¢ãµãŒãã¹ã«ã¯ç»é²ãããŠããªãè³æã§ãã
åãã¬ãã¥ãŒã瀺ããPLLAã®ææ°ã¯ãåç©å®éšãæ ¹æ ãšããŸããããã®å®éšã¯ããŠã¹ãæé·8é±ãŸã§èгå¯ããããã人ã®é¡ã§å¹æãäœãæç¶ããã瀺ãè³æãšã¯æ§æ Œãç°ãªããŸãã
PDOãšPLLAã¯äºãã«ç°ãªãç©è³ªã§ããPCLãŸã§å«ãã3çŽ æãçŽæ¥æ¯èŒããè³æããçŸæç¹ã§ã¯åç©å®éšã§ããããçŽ æã®çµæããå¥ã®çŽ æã®æç¶æéã®æ ¹æ ãšããŠèªã¿æ¿ããããšã¯ã§ããŸããã
çŽ æãšåãããç³žã®æ§é ãšé 眮ãéèŠã§ã
補åã«ãã£ãŠã衚é¢ãæ»ãããªãã®ãçµç¹ã«ãããããŒãããããã®ãã³ãŒã³ç¶ã®æ§é ç©ãä»ããŠãããã®ããããŸããçµç¹ãæããæ¹åŒãäºãã«ç°ãªããããçŽ æåãšæ¬æ°ã ãã§ã¯åãæœè¡ãšã¯èšããŸããã
å®éã®èšºçèšé²111,948ä»¶ãåæããè³æã§ã¯ãäžã€ã®çŽ æã®çµã¿åããã確èªãããPDOãšPCLã䜵çšããçµã¿åãããæãå€ããªããŸããããã£ã©ãŒã»ããã·ã³ãªã©ä»ã®æœè¡ãšåãææã«è¡ãããäŸã60%以äžã§ããããã®æ°åã¯ãã©ã®çµã¿åãããããé·ãç¶ãããŸãã¯ããå®å šã ãšããæ¯èŒçµæã§ã¯ãªããå®éã®äœ¿çšåŸåã瀺ããŸãã
æ¬æ°ãåç¬ã®åºæºãšããŠçšããã®ã¯é£ããã§ãã人22人ã60æ¥ãŸã§ã¿ã詊éšã§ã¯ãé¡ã®çåŽã«3æ¬å ¥ããå Žåãš6æ¬å ¥ããå Žåã®ããã ã«ã枬å®ãããå·®ã¯ãããŸããã§ãããã«ãŠã³ã»ãªã³ã°ã§ã¯ãæ°åããããã©ã®éšäœãšæ·±ãã«ã©ã®æ¹åã§é 眮ããããããããŠç¢ºèªããæ¹ãããã§ãã
å¯åå¿ã¯ç³žã®çš®é¡ãšå¹Žéœ¢ã«ãã£ãŠç°ãªãéèšã«ãªããŸãã
ç ç©¶26ç·šã®çµæãåããããšãæµ®è «ãæãå€ãå ±åãããç®èã®é¥å¹ã»ç³žãè§ŠãããéããŠèŠãããããçŸè±¡ã»ææãç¶ããŸãããäœå ã§æº¶ããç³žãšæº¶ããªã糞ã«åãããšããã³ãã»æèŠé麻ãšç³žã®é²åºã§å·®ãåºãŸããã
| é ç® | 確èªãããæ°å€ | æ¯èŒåºæº |
|---|---|---|
| æµ®è « | 35% | å šè³æãåç®ããå€ |
| ç®èã®é¥å¹ | 10% | å šè³æãåç®ããå€ |
| 糞ãè§ŠãããéããŠèŠãã | 4% | å šè³æãåç®ããå€ |
| ææ | 2% | å šè³æãåç®ããå€ |
| ãã³ãã»æèŠé麻 | 3.1%察11.7% | äœå ã§æº¶ãã糞察溶ããªã糞 |
| 糞ã®é²åº | 1.6%察7.6% | äœå ã§æº¶ãã糞察溶ããªã糞 |
| ç®èã®é¥å¹ã»ææ | é¥å¹ 16%察5.6% ææ 5.9%察0.7% |
50æ³è¶ 察50æ³ä»¥äž |
â» äžèš4é ç®ã¯ç ç©¶26ç·šãåç®ããå€ã§ãããé ç®ããšã«äœäººäžäœäººãã¯ãå ¬éãããèŠçŽã«ã¯ç€ºãããŠããŸããã
æºè¶³åºŠã¯æœè¡çŽåŸ98%ãé·æã®æç¹ã§ã¯88%ã§ãããæºè¶³åºŠããåžåæéãšåãæ°åãšããŠã¯è§£éããŸããã
ç±æãšèµ€ã¿ãå¢ããçºç±ã糞ã®é²åºã倧ãããªãé¥å¹ãçŸããããæœè¡ãåããå»çæ©é¢ã«ããé£çµ¡ããŠãã ããã糞ã®çš®é¡å¥ã®å埩管çã¯ãªããã£ã³ã°åŸã®ã±ã¢ã¬ã€ãã«ãäžè¬çãªå¯åå¿ãžã®å¯Ÿå¿ã¯æœè¡ã®å®å šæ¡å ã«ãŸãšããŠããŸãã
åãPDOã§ããèš±å¯ãããçšéã¯ç°ãªãå ŽåããããŸã
éåœã§ã¯ããªããã£ã³ã°çšã®ç³žã¯åµãçž«ãæè¡çšçž«å糞ãšå¥ã®åç®ãšããŠç®¡çãããŸããçŽ æãåãPDOã§ããçšéãç°ãªãã°èš±å¯ãå¥ã«åããŸãããããã£ãŠãæè¡ã§äœ¿ã糞ã ããå®å šã ããšãã説æã ãã§ã¯ããªããã£ã³ã°çšã®ç³žã倿ãã«ããã§ãã
ç±³åœã§ãã補åããšã«èªããããçšéã¯ç°ãªããŸããããã³ãŒã³è£œåã¯é ¬ã®ç®äžçµç¹ãäžæçã«æã¡äžããŠåºå®ããçšéã§åžè²©ãèš±å¯ãããŸãããäžæ¹ãããPDOã¢ã補åã¯çµç¹ãçž«ãçšéã§èš±å¯ãããçµç¹ãæã¡äžãããæ¯ãããããç®çã§ã¯äœ¿ããªããšèšãããŠããŸãã
é¡ã®ã©ã€ã³ã»éŠã»é¡ã®æœè¡ãšã³ã©ãŒã²ã³åºæ¿ã¯ã確èªãããç±³åœææžã®èš±å¯çšéã«å«ãŸããŠããŸããã§ããã補åã®çŽ æåã ããèŠããå®éã«äœ¿ã補åãã©ã®éšäœãšç®çã§èš±å¯ãããŠãããã確èªããå¿ èŠããããŸãã
æ¬æ°ãšææ°ããå ã«å°ããããš
èŠç©ãããæ¯èŒãããšãã¯ãæ°åã ããããããããããåãçš®é¡ãšåãæœè¡èšç»ãæ¯èŒããŠãããã確èªããå¿ èŠããããŸãã
- â¡ çŽ æ: PDOã»PLLAã»PCLã®ãã¡äœã䜿ããéžãã çç±ã¯äœã§ããïŒ
- â¡ æ§é : æ»ãããªç³žãããŒãã®ãã糞ãã³ãŒã³æ§é ç©ã®ä»ãã糞ã®ãã¡ã©ãã§ããïŒ
- â¡ æ·±ããšé å: ã©ã®å±€ã«äœæ¬ãã©ã®æ¹åã§å ¥ããŸããïŒ
- â¡ å埩: ããã¿ã»å åºè¡ã»çã¿ã¯ã©ã管çããã©ã®çç¶ã§ããé£çµ¡ãã¹ãã§ããïŒ
- â¡ åæœè¡: å®ããããææ°ãšãçŸåšæ®ã£ãŠããå€åã®ãã¡ãäœãåºæºã«ææã決ããŸããïŒ
- ⡠䜵çš: ãã£ã©ãŒã»ããã·ã³ã»ãšãã«ã®ãŒæœè¡ãšã®é çªãšééã¯ã©ãåããŸããïŒ
- â¡ å±¥æŽ: 以åã®ã¹ã¬ãããªããã»ãã£ã©ãŒã»æè¡ã®å±¥æŽãèšç»ã«ã©ãåæ ããŸããïŒ
- â¡ è²»çš: çŽ æã»æ§é ã»æ¬æ°ã«ãã£ãŠè²»çšã¯ã©ãå€ãããŸããïŒ
è€æ°ã®èŠç©ããã䞊ã¹ãŠèŠããšãã«ããããé ç®ã¯ãç®èç§ã®äŸ¡æ Œæ¯èŒãèŠç©æžã§ç¢ºèªãã6ã€ã®é ç®ã§ç¢ºèªã§ããŸãã
ãããã質å
Q1. ã¹ã¬ãããªããã®å¹æã¯ã©ããããç¶ããŸããïŒ
PDO 6ã8ãæã¯åžåæéã§ããå¹æã®æéã¯åãæ°åã§ã¯å®ããã人ã察象ã«ããè³æã§ã¯20æ¥ã«èŠãããåæå€åã60æ¥ã«æžå°ããŸãããåæœè¡ã®ææã¯ãçŸåšæ®ã£ãŠããå€åãšä»¥åã®æœè¡æŽãåºæºã«æ±ºããŸãã
Q2. 糞ãå€ãå ¥ãããšå¹æã倧ãããªããŸããïŒ
人ã察象ã«ãã詊éšã§ã¯ã3æ¬ãš6æ¬ã®ããã ã«æž¬å®ãããå·®ã¯ãããŸããã§ããã ãã®çµæã¯ãåœè©²è©Šéšã®æ¬æ°ãš60æ¥ã®èгå¯ç¯å²ã«è©²åœããŸããæ¬æ°ãšããããŠãæ¿å ¥éšäœã»æ·±ãã»æ¹åã確èªããŠãã ããã
Q3. äœå ã§æº¶ãã糞ã¯å¯åå¿ãå°ãªãã§ããïŒ
ç ç©¶ãåãããçµæã§ã¯ããã³ãã»æèŠé麻ãšç³žã®é²åºããäœå ã§æº¶ãã糞ã§ããäœãéèšãããŸãããæµ®è «ã»é¥å¹ãªã©ä»ã®é ç®ãŸã§ããã¹ãŠåãå·®ã瀺ãããšããæå³ã§ã¯ãããŸããã
Q4. ã¹ã¬ãããªããã®ããšããã£ã©ãŒãããã·ã³ãäžç·ã«åããŠãããã§ããïŒ
å€§èŠæš¡ãªèšºçèšé²ã§ã¯ã60%以äžãä»ã®æœè¡ãšåãææã«å®æœãããŸããããã®æ°å€ã¯äœµçšã®é »åºŠã瀺ããŸããåããæœè¡åãšæ¥ä»ãäŒããéšäœããšã®é çªãšééãæ±ºããŠãã ããã詳ããåºæºã¯ãªããã£ã³ã°ã»ã¬ãŒã¶ãŒã»ã¹ãã³ããŒã¹ã¿ãŒã®é åºã¬ã€ãã«ãŸãšããŠããŸãã
Q5. æœè¡åŸãã©ã®ãããªçç¶ãåºããç é¢ã«é£çµ¡ãã¹ãã§ããïŒ
匷ãŸãç±æã»èµ€ã¿ãçºç±ãç®èã®å€ã«åºã糞ã倧ãããªãé¥å¹ãçŸããããæœè¡ãåããå»çæ©é¢ã«ããé£çµ¡ããŠãã ãããäžè¬çãªå埩管çãšé£çµ¡ã®åºæºã¯ããªããã£ã³ã°åŸã®ã±ã¢ã¬ã€ããšæœè¡ã®å®å šæ¡å ã§ç¢ºèªã§ããŸãã
çµæã»æç¶ã»é©åã®å¯åŠã¯ããäžäººãã²ãšãã®èç¶æ ã»å¹Žéœ¢ã»çæŽ»ç¿æ £ã«ãã£ãŠå·®ããããåãçµæããçŽæããããšã¯ã§ããŸããã
æœè¡ã«ã¯äžæçãªèµ€ã¿ã»ããã¿ãªã©ã®å¯åå¿ãçããå¯èœæ§ããããçŠå¿äºé ãããå ŽåããããŸãã®ã§ãäºåã«ãŠã³ã»ãªã³ã°ã§ã確èªãã ããã
æ¬èšäºã¯äžè¬çãªæ å ±ã®ãæ¡å ã§ãããåå¥ã®èšºçã«ä»£ãããã®ã§ã¯ãããŸããããèªèº«ã®ç¶æ ã«åããã蚺æã»æœè¡ã¯ã«ãŠã³ã»ãªã³ã°ã§ã確èªãã ããã
æ ¹æ è³æ
- Yi KH ã»ã, Clin Cosmet Investig Dermatol 2024 (PMID 38737945) â 確èªç¯å²: å šæãšåèæç®ã®åæãåžåæéã®æã®è泚ãæãè³æã¯ã2017幎ã®åŠè¡èªåµåå·ã«æ²èŒããã1ããŒãžã®åèè³æã§ãããPubMedãšEurope PMCã«çŽ¢åŒãããŠããŸãããã¬ãã¥ãŒã瀺ããPLLAã®æç¶æéã¯ãç¡æ¯ããŠã¹30å¹ã1é±ã»4é±ã»8é±ã§è©äŸ¡ããåç©å®éšãæ ¹æ ãšããŸãããéç: æ€çŽ¢ã»éžå®æç¶ãããããããå®ããŠããªãåè¿°çã¬ãã¥ãŒã§ãã
- FDA 510(k) K251414 â 確èªç¯å²: åæPDFã4-0èŠæ Œã®2é±çŽ81%ã»4é±çŽ66%ã®æ®å匷床ãMiracu PDO MONOã®èš±å¯çšéãšæäžã»æ¯æç®çã®é€å€æèšãéç: åäžè£œåèŠæ Œã®è©Šéšå€ã§ãã
- Niu Z ã»ã, Aesthetic Plast Surg 2021 (PMID 33821308) â 確èªç¯å²: æé²ã26ç·šã¡ã¿åæã®çµ±åçºççãåžåæ§ã»å¹Žéœ¢ã®å±€å¥ãæºè¶³åºŠ98%ãš88%ãéç: æé²ã«å šäœã®åå è æ°ãšé ç®å¥ã®åæ¯ããªããæ ¹æ ççŽã¯IIIã§ãã
- Germani M ã»ã, Aesthet Surg J Open Forum 2025 (PMID 40236886) â 確èªç¯å²: æé²ã22人ãçåŽ3æ¬å¯Ÿ6æ¬ã20æ¥ã»60æ¥ã®äžæ¬¡å èšæž¬ã矀éå·®ãªããš60æ¥ã®æžå°ãéç: å°èŠæš¡ã§ããã远跡ã¯60æ¥ã§çµãããŸããã
- Riopelle AM ã»ã, Dermatol Surg 2025 (PMID 39662017) â 確èªç¯å²: æé²ã12ç·šã»818人ã®ç³»çµ±çæç®ã¬ãã¥ãŒãæœè¡çŽåŸã®æ¹åãæé·è¿œè·¡2幎ãé·ææå¹æ§è³æãäžè¶³ããŠãããšããçµè«ãéç: å šæã¯ç¢ºèªã§ããŸããã§ããã
- FDA 510(k) K212380 · K243897 â 確èªç¯å²: 510(k) SummaryåæPDFãPDOã®ååŠåpoly(p-dioxanone)ãšåååŒ(C4H6O3)nãæå€§6é±ã®åµæ¯æã®æèšãæž¬å®æç¹0ã»14ã»28ã»42æ¥ãPLLAã¯ä¹³é žããåŸãã©ã¯ããã§äœãç©è³ªã§ãããããPDOãšåºçºç©è³ªãç°ãªããŸããéç: èŠå¶å¯©æ»ææžã§ãããæäžå¹æã枬ã£ãç ç©¶ã§ã¯ãããŸããã
- FDA 510(k) K142061 · K163676 â 確èªç¯å²: Indications for Useãš510(k) SummaryåæPDFãäžé¡é¢ã®é ¬ç®äžçµç¹ã®åºå®ãšããçšéç¯å²ã2017å¹Žææžã«è¿œå ãããtemporarilyãåãçŽ æã§äœã£ã糞ãšåæ¹åã³ãŒã³4åã»6åã»8åã®æ§æã20人ã1é±ã»8é±ã»12é±ã§è©äŸ¡ããèšåºãéç: èšåºèŠæš¡ã¯20人ã»12é±ã§ãã
- åœå®¶æ³ä»€æ å ±ã»ã³ã¿ãŒããå»çæ©åšã®åç®åã³åç®å¥ççŽã«é¢ããèŠå®ãå¥è¡š1 â 確èªç¯å²: å¥è¡šPDFåæãB02040.01é¡é¢çµç¹åºå®çšç³žã®å®çŸ©ãš4ççŽãå¯Ÿç §åç®B02020.20ãåãPDOçŽ æã§ãããªããã£ã³ã°çšã®ç³žãšæè¡çšçž«å糞ã¯å¥åç®ã«åé¡ãããŸããéç: åå¥è£œåã®èš±å¯çªå·ã¯ç¢ºèªããŠããŸããã
- Tamura T ã»ã, Plast Reconstr Surg Glob Open 2025 (PMID 41346928) â 確èªç¯å²: å šæã2020幎ãã2024幎ãŸã§100ãæãè¶ ããç é¢ã®èšºçèšé²111,948ä»¶ã§ãçŽ æã®çµã¿åããäžã€ãPDOã»PCLçµã¿åãããæå€ã60%以äžã®äœµçšã確èªããŸãããè«æã玹ä»ããå¯åå¿æ°å€ã®åæ¯ã¯ãå¥ã®èгå¯ç ç©¶342人ã§ããéç: åäžäŒæ¥éå£ã®å©çšåŸåã®åæã§ãã
- Soen M ã»ã, Iran J Basic Med Sci 2025 (PMID 39850124) â 確èªç¯å²: æé²ãUVBã4é±éç §å°ããéã©ãã30å¹ã§ãPDOã»PLLAã»PCLããããç®èäžã®ã³ã©ãŒã²ã³ãå¢ããPCLçŸ€ã®æ°å€ãããé«ããªããŸãããã³ã©ãŒã²ã³éãšé¢é£éºäŒåã®æŽ»åãæ¯èŒããåç©å®éšã§ãã
- Cho SW ã»ã, J Cosmet Dermatol 2021 (PMID 33421303) â 確èªç¯å²: æé²ãç¡æ¯ããŠã¹30å¹ã1é±ã»4é±ã»8é±ã«çæ€ããŠè©äŸ¡ãéç: æé·ã®èг坿ç¹ã¯8é±ã§ãã
ããããŠèªã
- ãªããã£ã³ã°åŸã®ã±ã¢ã糞ã®çš®é¡ã§äœãéãã
- ãªããã£ã³ã°ã»ã¬ãŒã¶ãŒã»ã¹ãã³ããŒã¹ã¿ãŒã®é åºã®æ±ºãæ¹
- éæè¡ãªããã£ã³ã°ã®éžæè¢ã®æ¯èŒ
- èã®ããªãèœã¡ãçç±ãšæœè¡ã®éžæåºæº
- ç®èç§ã®äŸ¡æ Œæ¯èŒãèŠç©æžã§ç¢ºèªãã6ã€ã®é ç®
- ã»ãªããã¯å»é¢ïŒCelliniqueïŒã®æœè¡æ¡å
- æœè¡ã®å®å šã»å¯åå¿ã®ãæ¡å
åºå ž
- ì€ëЬíí ë¶ìì© ë©íë¶ì 26íž: í¡ìì±Â·ë¹í¡ìì± ë° ì°ë ¹ ìžµí (PMID 33821308)PubMed (Aesthetic Plastic Surgery)
- PDO ì€ 3ê°ë¥ ë 6ê°ë¥ 묎ìì ë¹êµìí n=22, 20·60ìŒ 3D ê³ìž¡ (PMID 40236886)PubMed (Aesthetic Surgery Journal Open Forum)
- ì€ëЬíí 첎ê³ì 묞íê³ ì°° 12íž 818ëª , ìµì¥ ì¶ì 2ë (PMID 39662017)PubMed (Dermatologic Surgery)
- PDO·PLLA·PCL í¡ì êž°ê° ìì í 늬뷰 â 1ì°š 귌거ì ì¶ì² ì¶ì ëì (PMID 38737945)PubMed (Clin Cosmet Investig Dermatol)
- FDA 510(k) K163676: ì€ì멎 íŒíì¡°ì§ ìŒì ê³ ì ì ììŠÂ·ìì n=20U.S. FDA
çŸåšã®ç¶æ ã«åãæœè¡çžè«
çŸåšã®å¥åº·ç¶æ ãšéå»ã®æœè¡æŽã確èªããããã§ãæ€èšå¯èœãªéžæè¢ãšéçããæ¡å ããŸãã



